Atea Pharmaceuticals Inc (AVIR) stock is lower by -74.81% over the last 12 months, and the average rating from Wall Street analysts is a Buy. InvestorsObserver’s proprietary ranking system, gives AVIR stock a score of 24 out of a possible 100.
That rank is mainly influenced by a long-term technical score of 1. AVIR's rank also includes a short-term technical score of 8. The fundamental score for AVIR is 62. In addition to the average rating from Wall Street analysts, AVIR stock has a mean target price of $13.67. This means analysts expect the stock to rise 49.85% over the next 12 months.
AVIR has an Overall Score of 24. Find out what this means to you and get the rest of the rankings on AVIR!
Atea Pharmaceuticals Inc (AVIR) stock is higher by 6.54% while the S&P 500 is higher by 0.72% as of 11:33 AM on Wednesday, Dec 22. AVIR is higher by $0.56 from the previous closing price of $8.56 on volume of 730,292 shares. Over the past year the S&P 500 is up 26.99% while AVIR is lower by -74.81%. AVIR earned $0.27 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 33.49.
Click Here to get the full Stock Report for Atea Pharmaceuticals Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
